Clinical TrialsSearch results
Number of results: 2568
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2007-09-01
Other
- A phase I/II study of UMN-0501 (prepandemic recombinant hemagglutinin influenza vaccine) administrated intramuscularly in healthy, 20 to 40 years of age, male volunteers investigating it's safety, tolerability and immunogenicity. (single center, ascending doses, open label)
- Prevention of influenza pandemic
- UMN Pharma Inc.
- 2008-06-18
Other
- A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)
- Symptomatic uterine leimoyoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase I/II study of weekly paclitaxel therapy for metastatic gastric cancer (Step 2)
- Fluoropyrimidine failure metastatic gastric cancer
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- A Phase I/II, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic Non-small Cell Lung Cancer
- Non-Small-Cell Lung Carcinoma
- Hibi Kazushige
- 2022-08-27
Recruiting
- A Phase I/II.a Investigator-initiated Study of ADR-001 in Combination With Nivolumab in Cancer Patients With Acquired Resistance to Immune Checkpoint Inhibitors
- Solid cancers such as lung cancer, esophageal cancer, stomach cancer, etc.
- Wada Satoshi
- 2024-04-10
Recruiting
- A Phase I/IIa Multi-center, Open-label Master Protocol to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of AZD8205 in Participants With Advanced or Metastatic Solid Malignancies
- Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer, Endometrial Cancer
- Hibi Kazushige
- 2022-01-28
Recruiting
- A Phase I/IIa Open-label Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD7789, an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Participants With Advanced or Metastatic Solid Tumors.
- Advanced or Metastatic Solid Tumors
- Hibi Kazushige
- 2023-03-02